164 related articles for article (PubMed ID: 8105794)
21. Definition of an epitope on NS3 recognized by human CD4+ cytotoxic T lymphocyte clones cross-reactive for dengue virus types 2, 3, and 4.
Kurane I; Zeng L; Brinton MA; Ennis FA
Virology; 1998 Jan; 240(2):169-74. PubMed ID: 9454689
[TBL] [Abstract][Full Text] [Related]
22. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
Yasukawa M; Zarling JM
J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
[TBL] [Abstract][Full Text] [Related]
23. Flavivirus-cross-reactive, HLA-DR15-restricted epitope on NS3 recognized by human CD4+ CD8- cytotoxic T lymphocyte clones.
Kurane I; Okamoto Y; Dai LC; Zeng LL; Brinton MA; Ennis FA
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2243-9. PubMed ID: 7561761
[TBL] [Abstract][Full Text] [Related]
24. Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants.
Plotnicky H; Touraine JL
Clin Exp Immunol; 1993 Dec; 94(3):494-9. PubMed ID: 7504600
[TBL] [Abstract][Full Text] [Related]
25. Differential in vitro activation of CD4+CD8- and CD8+CD4- herpes simplex virus-specific human cytotoxic T cells.
Yasukawa M; Inatsuki A; Kobayashi Y
J Immunol; 1989 Sep; 143(6):2051-7. PubMed ID: 2476493
[TBL] [Abstract][Full Text] [Related]
26. Activation of HLA-restricted EBV-specific cytotoxic T cells does not require CD4+ (helper) T cells or exogenous cytokines.
Fishwild DM; Benike CJ; Engleman EG
J Immunol; 1988 Mar; 140(6):1994-8. PubMed ID: 2831276
[TBL] [Abstract][Full Text] [Related]
27. Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes.
Bukowski JF; Kurane I; Lai CJ; Bray M; Falgout B; Ennis FA
J Virol; 1989 Dec; 63(12):5086-91. PubMed ID: 2511337
[TBL] [Abstract][Full Text] [Related]
28. Cloned human CD4+ cytotoxic T lymphocytes specific for Toxoplasma gondii lyse tachyzoite-infected target cells.
Curiel TJ; Krug EC; Purner MB; Poignard P; Berens RL
J Immunol; 1993 Aug; 151(4):2024-31. PubMed ID: 8102155
[TBL] [Abstract][Full Text] [Related]
29. Specific killing of cytotoxic T cells and antigen-presenting cells by CD4+ cytotoxic T cell clones. A novel potentially immunoregulatory T-T cell interaction in man.
Ottenhoff TH; Mutis T
J Exp Med; 1990 Jun; 171(6):2011-24. PubMed ID: 1972178
[TBL] [Abstract][Full Text] [Related]
30. Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones.
Gagnon SJ; Ennis FA; Rothman AL
J Virol; 1999 May; 73(5):3623-9. PubMed ID: 10196254
[TBL] [Abstract][Full Text] [Related]
31. Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones.
Koide J; Engleman EG
J Immunol; 1990 Jan; 144(1):32-40. PubMed ID: 1967266
[TBL] [Abstract][Full Text] [Related]
32. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD
AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847
[TBL] [Abstract][Full Text] [Related]
33. In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340.
Ulaeto D; Wallace L; Morgan A; Morein B; Rickinson AB
Eur J Immunol; 1988 Nov; 18(11):1689-97. PubMed ID: 2904885
[TBL] [Abstract][Full Text] [Related]
34. Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements.
Gervois N; Heuze F; Diez E; Jotereau F
Eur J Immunol; 1990 Apr; 20(4):825-31. PubMed ID: 1971794
[TBL] [Abstract][Full Text] [Related]
35. Dengue virus-specific memory T cell responses in human volunteers receiving a live attenuated dengue virus type 2 candidate vaccine.
Dharakul T; Kurane I; Bhamarapravati N; Yoksan S; Vaughn DW; Hoke CH; Ennis FA
J Infect Dis; 1994 Jul; 170(1):27-33. PubMed ID: 7912253
[TBL] [Abstract][Full Text] [Related]
36. Lysis of CD4+ lymphocytes by non-HLA-restricted cytotoxic T lymphocytes from HIV-infected individuals.
Grant MD; Smaill FM; Rosenthal KL
Clin Exp Immunol; 1993 Sep; 93(3):356-62. PubMed ID: 8103717
[TBL] [Abstract][Full Text] [Related]
37. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
[TBL] [Abstract][Full Text] [Related]
38. Quantitation of dengue virus specific CD4+ T cells by intracellular cytokine staining.
Mangada MM; Ennis FA; Rothman AL
J Immunol Methods; 2004 Jan; 284(1-2):89-97. PubMed ID: 14736419
[TBL] [Abstract][Full Text] [Related]
39. Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1.
Duan Z; Guo J; Huang X; Liu H; Chen X; Jiang M; Wen J
J Med Virol; 2015 Jul; 87(7):1077-89. PubMed ID: 25777343
[TBL] [Abstract][Full Text] [Related]
40. Partial agonist effect influences the CTL response to a heterologous dengue virus serotype.
Zivny J; DeFronzo M; Jarry W; Jameson J; Cruz J; Ennis FA; Rothman AL
J Immunol; 1999 Sep; 163(5):2754-60. PubMed ID: 10453018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
